最新消息
立即訂閱 0
💎 挖掘低估值寶藏股
立即開始
關閉

Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund R Inc(0P0000OMT9)

建立提醒
新的!
建立提醒
網站
  • 作為提醒通知
  • 您要登陸到您的賬戶才能使用此功能
移動應用程序
  • 您要登陸到您的賬戶才能使用此功能
  • 請確保您使用相同的用戶資料登入

條件

頻率

一次
%

頻率

頻率

傳達方式

狀態

從投資組合中新增/移除 新增至觀察名單
加入觀察名單
新增持倉盤

頭寸被成功添加到:

請為您的持倉投資組合命名
 
70.860 +0.640    +0.91%
01/11 - 延遲資料. EUR 貨幣
種類:  基金
市場:  愛爾蘭
發行者:  Polar Capital LLP
國際證券識別碼(ISIN):  IE00B3NLSS43 
資產類別:  股票
  • 晨星評級:
  • 總資產: 1.92B
Polar Capital Funds PLC - Polar Capital Healthcare 70.860 +0.640 +0.91%

0P0000OMT9綜觀

 
你可在本頁找到深入的Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund R Inc公司檔案,包括0P0000OMT9的主要管理層、總資產、投資策略及聯絡資料,以及各類其他資訊。
類別

Sector Equity Healthcare

總資產

1.92B

費用

1.23%

基金成立

2009年4月1日

聯絡資訊

地址 16 Palace Street
London,England SW1E 5JD
United Kingdom
電話 44 (0)20 7227 2700

主要管理層

名稱 主旨 成立於 直至
James Douglas - 2015 now
自傳 James joined Polar Capital in September 2015 and is a Fund Manager for the Healthcare team. He was appointed Co-Fund Manager for the Polar Capital Global Healthcare Trust in May 2017.Prior to joining Polar Capital, James worked in equity sales specialising in global healthcare at Morgan Stanley, RBS and HSBC. James also has equity research experience garnered from his time at UBS, where he worked as an analyst in the European pharmaceutical and biotechnology team. Before moving across to the financial sector, he worked as a consultant for EvaluatePharma. James received a PhD and first class honours degree in Medicinal Chemistry from Newcastle University. Further to this, James also holds an ACCA diploma in financial management.
Gareth Powell Portfolio Manager 2007 now
自傳 Gareth Powell joined Polar Capital in 2007 to establish the healthcare investment team. He is joint manager of the Healthcare Opportunities Fund. He joined Framlington in 1999, later becoming a portfolio manager on the Framlington Health Fund. In 2002, Gareth helped launch the Framlington Biotech Fund, which he managed until his departure. Gareth studied biochemistry at Oxford, during which time he worked at Yamanouchi, a leading Japanese pharmaceutical company (later to become Astellas), as well as various academic laboratories including the Sir William Dunn School of Pathology, the Wolfson Institute for Biomedical Research and Oxford Business School. He is a CFA charterholder.
Daniel Mahony Portfolio Manager 2007 2019
自傳 Daniel Mahony Ph.D. joined Polar Capital to establish the healthcare investment team in 2007. He is joint manager of the Healthcare Opportunities Fund and lead manager of the Healthcare Blue Chip Fund. Prior to joining Polar Capital, he was head of the European healthcare research team at Morgan Stanley, covering the European biotechnology, medical technology and healthcare services sectors. He also previously worked in New York for ING Barings Furman Selz following the US biotechnology sector. Before working in the investment field, Daniel worked as a research scientist for seven years with the majority of his time at Schering Plough Corporation in California. Daniel received his PhD from Cambridge University in 1995 and a first class honours degree in biochemistry from Oxford University in 1991.
評論守則
我们鼓励您使用评论,与用户沟通,共享您的观点并向作者及互相提问。 但是,为了获得有价值和期待的高水平评论,请注意以下标准:
  • 丰富对话
  • 保持关注及正确方向。 只发布与所讨论话题相关的材料。
  • 保持尊重。 即使是负面的意见,也可以用积极的外交辞令进行组织。
  • 用标准书写风格。 包括标点和大小写。
  • 注: 评论中如有垃圾和/或促销信息和链接都将被删除。
  • 避免亵渎、诽谤或人身攻击,对于作者或其他用户。
  • 仅允许中文评论。

垃圾邮件或滥发信息的肇事者都将被从网站删除并禁止以后进行注册,这由Investing.com自由决定。

0P0000OMT9評論

寫下您對Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund R Inc的看法
 
確定要刪除這個圖表?
 
留言
也張貼至:
 
用新的圖表更換附上的圖表?
1000
由於收到負面的用戶報告,你的評論功能已被暫停。你的狀態會由版主審核。
請等待一分鐘后再次發表評論。
感謝您的評論。請註意,所有的評論都需要我們版主的批準。因此,可能過一些時間您的評論才會出現在我們的網站上。
 
確定要刪除這個圖表?
 
留言
 
用新的圖表更換附上的圖表?
1000
由於收到負面的用戶報告,你的評論功能已被暫停。你的狀態會由版主審核。
請等待一分鐘后再次發表評論。
在留言中加插圖表
確認封鎖

你確定要封鎖 %USER_NAME%?

此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。

%USER_NAME% 已成功加入你的封鎖清單

你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。

舉報此評論

我覺得這個評論是:

評論被加標記

謝謝!

您的報告已被發送到我們的版主審核
使用 Apple 登入
以 Google 登入
以電子郵件註冊